# Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques

> **NCT06957821** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Carotid Artery Diseases
- Peripheral Arterial Disease

## Interventions

- **DRUG:** Pegulicianine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06957821
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-07
- **Final completion:** 2029-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06957821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06957821, "Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT06957821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*